Literature DB >> 31400533

Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.

Ashley E Stenzel1, Matthew F Buas1, Kirsten B Moysich2.   

Abstract

OBJECTIVE: Update information on racial disparities in ovarian cancer survival from the Surveillance, Epidemiology, and End Results (SEER) Program.
METHODS: Data on women with epithelial ovarian cancer from the SEER Program between 1995-2015 were collected including; patient ID, age at diagnosis, year of diagnosis, surgery, chemotherapy, radiation, insurance status, region of registry, tumor grade, tumor histology, tumor summary stage, survival months, race/ethnicity, and vital status. Multivariable analyses were performed to examine overall survival, differences in survival by age at diagnosis, by year of diagnosis, risk of not receiving surgery, and risk of 12-month death across racial/ethnic groups.
RESULTS: Non-Hispanic black women (n = 4261) had an increased risk of overall mortality (HR = 1.28, CI: 1.23-1.33) when compared to non-Hispanic white women (n = 47,475), which appears more pronounced among women diagnosed under age 50. Hispanic women (n = 7052) had no difference in survival when compared to non-Hispanic white women (HR = 1.03, CI: 0.99-1.07). Non-Hispanic Asian/PI women (n = 5008) exhibited slightly reduced risk (HR = 0.95, CI: 0.91-0.99) when compared to non-Hispanic white women. Risk of not receiving surgical intervention remains high among non-Hispanic black women and Hispanic women, when compared to non-Hispanic white women. Non-Hispanic black women, non-Hispanic Asian/PI women, and Hispanic women were all at significantly greater risk of dying within the first 12 months of cancer diagnosis when compared to non-Hispanic white women.
CONCLUSION: Disparities in survival remain across various racial/ethnic groups, when compared to non-Hispanic white women with ovarian cancer. These disparities should continue to be examined in an effort to decrease such gaps.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ethnicity; Fatal; Mortality; Ovarian; Race; Risk; Surgery; Survival

Mesh:

Year:  2019        PMID: 31400533     DOI: 10.1016/j.canep.2019.101580

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  11 in total

1.  Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study.

Authors:  Dong Wook Shin; Jaeman Bae; Johyun Ha; Kyu-Won Jung
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

2.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

3.  Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K.

Authors:  Li Geng; Zhongqiu Wang; Yongju Tian
Journal:  J Ovarian Res       Date:  2022-01-03       Impact factor: 4.234

4.  Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.

Authors:  Qingyang Liu; Hao Zhang; Xiaocheng Yang; Xuesong Liu; Fanxing Yin; Panpan Guo; Yuhan Yin; Kaijiang Zheng; Zhuo Yang; Yanshuo Han
Journal:  Ann Transl Med       Date:  2022-01

Review 5.  Ferroptosis: A New Strategy for Cancer Therapy.

Authors:  Yu Chen; Zhihua Fan; Shen Hu; Chengchao Lu; Yi Xiang; Shuzhi Liao
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

6.  Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.

Authors:  Sarah P Huepenbecker; Charlotte C Sun; Shuangshuang Fu; Hui Zhao; Kristin Primm; Sharon H Giordano; Larissa A Meyer
Journal:  Cancer       Date:  2021-08-04       Impact factor: 6.860

7.  Ambient air pollution and ovarian cancer survival in California.

Authors:  Carolina Villanueva; Jenny Chang; Argyrios Ziogas; Robert E Bristow; Verónica M Vieira
Journal:  Gynecol Oncol       Date:  2021-07-28       Impact factor: 5.304

8.  Race and Ethnicity Influence Survival Outcomes in Women of Caribbean Nativity With Epithelial Ovarian Cancer.

Authors:  Matthew Schlumbrecht; Danielle Cerbon; Melissa Castillo; Scott Jordan; Raleigh Butler; Andre Pinto; Sophia George
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

9.  Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.

Authors:  Chen-Yu Huang; Min Cheng; Na-Rong Lee; Hsin-Yi Huang; Wen-Ling Lee; Wen-Hsun Chang; Peng-Hui Wang
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

Review 10.  Protective Effects and Benefits of Olive Oil and Its Extracts on Women's Health.

Authors:  Thanh Truong Giang Ly; Jisoo Yun; Dong-Hyung Lee; Joo-Seop Chung; Sang-Mo Kwon
Journal:  Nutrients       Date:  2021-11-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.